Tentt

PAI Pharma Acquires Nivagen Pharmaceuticals

Announced
HealthcareCaliforniaPlatform

Deal Overview

PAI Pharma has acquired Nivagen Pharmaceuticals, expanding its domestic sterile injectable manufacturing footprint and broadening its ready-to-use (RTU) product offering for the hospital market.

The deal is positioned as a platform expansion for PAI Pharma in the healthcare/pharmacy sector, focused on sterile injectable production capabilities and RTU accessibility for hospital customers.

Key Details

Transaction
PAI Pharma acquires Nivagen Pharmaceuticals
Deal Size
Over $100M

Source

Read full article on news.google.com

via GN - acquired by PE · January 6, 2026

Powered by Tentt

Source healthcare deals in California for your firm

Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.

Book a 30-min intro call